Drug Shortage Report for ACT METHYLPHENIDATE ER
| Report ID | 65996 |
| Drug Identification Number | 02441950 |
| Brand name | ACT METHYLPHENIDATE ER |
| Common or Proper name | METHYLPHENIDATE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
| Strength(s) | 36MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N06BA |
| ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-02-28 |
| Estimated end date | 2024-02-10 |
| Actual end date | 2024-02-12 |
| Shortage status | Resolved |
| Updated date | 2024-02-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v41 | 2024-02-13 | English | Compare |
| v42 | 2024-02-13 | French | Compare |